Excitotoxic insults lead to peroxiredoxin hyperoxidation

Oxidative Medicine and Cellular Longevity

Volumn 2, Issue 2, 2009, Pages 110-113

  Léveillé, Frédéric ^a   Soriano, Francesc X ^a   Papadia, Sofia ^a   Hardingham, Giles E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Key words: peroxiredoxin, NMDA receptor, excitotoxicity, oxidative stress, synaptic activity, sulfiredoxin, stroke

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PEROXIREDOXIN; THIOREDOXIN; NEUROTOXIN;

ARTICLE; EXCITOTOXICITY; GENE EXPRESSION; HUMAN; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; ANIMAL; CELL CULTURE; METABOLISM; RAT;

ANIMALS; CELLS, CULTURED; GLUTAMIC ACID; NEUROTOXINS; OXIDATIVE STRESS; PEROXIREDOXINS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; THIOREDOXINS;

EID: 77953416102     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.2.2.8300     Document Type: Article

References (27)

1. Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 827:65-75.
2. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006; 97:1634-58.
3. Yoshida T, Nakamura H, Masutani H, Yodoi J. The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process. Ann N Y Acad Sci 2005; 1055:1-12.
4. Papadia S, Soriano FX, Leveille F, Martel MA, Dakin KA, Hansen HH, et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 2008; 11:476-87.
5. 3H-1,2-dithiole- 3-thione. J Neurochem 2008; 107:533-43.
6. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993; 364:535-7.
7. Bondy SC, Lee DK. Oxidative stress induced by glutamate receptor agonists. Brain Res 1993; 610:229-33.
8. Reynolds IJ, Hastings TG. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 1995; 15:3318-27.
9. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004; 61:657-68.
10. Nicholls DG, Johnson-Cadwell L, Vesce S, Jekabsons M, Yadava N. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J Neurosci Res 2007; 85:3206-12.
11. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002; 5:405-14.
12. Lee B, Butcher GQ, Hoyt KR, Impey S, Obrietan K. Activity-Dependent Neuroprotection and cAMP Response Element-Binding Protein (CREB): Kinase Coupling, Stimulus Intensity, and Temporal Regulation of CREB Phosphorylation at Serine 133. J Neurosci 2005; 25:1137-48.
13. 2+ and the cAMP response element-binding protein family mediate a late phase of activitydependent neuroprotection. J Neurosci 2005; 25:4279-87.
14. Lipton SA, Nakanishi N. Shakespeare in Love-with NMDA receptors? Nature Medicine 1999; 5:270-1.
15. Papadia S, Hardingham GE. The Dichotomy of NMDA Receptor Signaling. Neuroscientist 2007.
16. Soriano FX, Papadia S, Hofmann F, Hardingham NR, Bading H, Hardingham GE. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci 2006; 26:4509-18.
17. 2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. J Neurochem 2005; 93:171-85.
18. Soriano FX, Hardingham GE. Compartmentalized NMDA receptor signalling to survival and death. J Physiol 2007; 584:381-7.
19. Aarts MM, Tymianski M. TRPM7 and ischemic CNS injury. Neuroscientist 2005; 11:116-23.
20. 2+ signals and neuronal death in brain ischemia. Stroke; a journal of cerebral circulation 2007; 38:674-6.
21. Soriano FX, Martel MA, Papadia S, Vaslin A, Baxter P, Rickman C, et al. Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci 2008; 28:10696-710.
22. Besancon E, Guo S, Lok J, Tymianski M, Lo EH. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 2008; 29:268-75.
23. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovascular diseases (Basel, Switzerland) 2008; 25:268-78.
24. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. Febs J 2009; 276:13-26.
25. Bading H, Greenberg ME. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 1991; 253:912-4.
26. Bading H, Ginty DD, Greenberg ME. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993; 260:181-6.
27. Hardingham GE, Arnold FJ, Bading H. Nuclear calcium signaling controls CREBmediated gene expression triggered by synaptic activity. Nat Neurosci 2001; 4:261-7.